Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Wegener's Granulomatosis Etanercept Trial (WGET)

Trial Profile

Wegener's Granulomatosis Etanercept Trial (WGET)

Phase of Trial: Phase II/III

Latest Information Update: 20 Feb 2017

At a glance

  • Drugs Etanercept (Primary)
  • Indications Wegener's granulomatosis
  • Focus Therapeutic Use
  • Acronyms WGET
  • Most Recent Events

    No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top